CD4 and cancer: Given that cancer immunotherapy depends mainly on T-cell infiltration in the tumor immune microenvironment (11), we isolated CD3+ T cells, CD4+ T cells and CD8+ T cells from healthy human peripheral blood mononuclear cells (PBMCs) to performed a cytotoxicity assay (Figure 4A).